Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 3,655.00
-10.00 (-0.27%)
Oct 8, 2026, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 47.68 billion as of October 8, 2026. It is the 32,911th most valuable company in the world and the 1,884th biggest in South Korea. Its market cap has decreased by 55.27% in one year.
Market Cap
47.68B
Enterprise Value
31.46B
Revenue
395.50M
Global Rank
Country Rank
#1,884 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 18, 2024, Oncocross's market cap has decreased from 106.25B to 47.68B, a decrease of -55.12%. That is a compound annual growth rate of -35.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 47.68B | -58.62% |
| Dec 30, 2025 | 115.23B | 53.28% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sam Chun Dang Pharm. | 5.51T |
| PharmaResearch | 3.14T |
| Mezzion Pharma | 2.04T |
| ST Pharm | 1.93T |
| Oscotec | 1.44T |
| DongKook Pharmaceutical | 1.01T |
| Huons Global | 283.22B |
| KOLMAR BNH | 227.21B |